Search

everythinglearnresearchcommunity

for

Search:↓

The study aims to find the best platelet-rich plasma dose to relieve moderate carpal tunnel syndrome symptoms.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Tangent screens help detect visual field defects from vigabatrin.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A rare autoimmune condition, Satoyoshi syndrome, can start in adults and improve with immunosuppressive treatment.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

More severe hair loss worsens quality of life in men.

Goats with BSE or scrapie show varying symptoms, and using only clinical signs may not detect all scrapie cases.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Early screening for Metabolic Syndrome in hair loss patients can help prevent heart disease.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Increasing social support and acceptance can reduce self-stigma in alopecia areata patients.

Botulinum toxin Type A helps reduce hypertrophic scars and is generally safe.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

People with rheumatoid arthritis have poorer sleep quality than healthy individuals.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

The machine learning model accurately predicts Systemic Lupus Erythematosus in Omani patients.